Abstract
The encapsulated fungal pathogens Cryptococcus neoformans and Cryptococcus gattii are significant agents of life-threatening infections, particularly in persons with suppressed cell-mediated immunity. This chapter provides detailed methodology for the purification of two of the major antigen fractions of C. neoformans: glucuronoxylomannan (GXM) and mannoprotein (MP). GXM is the primary component of the polysaccharide capsule, which is the major cryptococcal virulence factor. In contrast, MPs have been identified as key antigens that stimulate T-cell responses. Purification of GXM and MP should assist investigators studying the antigenic, biochemical, and virulence properties of Cryptococcus species.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Levitz, S. M. (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Reviews of Infectious Diseases 13, 1163–1169.
Mitchell, T. G. & Perfect, J. R. (1995) Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clinical Microbiology Reviews 8, 515–548.
Shoham, S. & Levitz, S. M. (2005) The immune response to fungal infections. British Journal of Haematology 129, 569–582.
Singh, N., Gayowski, T., Wagener, M. M. & Marino, I. R. (1997) Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clinical Transplantation 11, 66–70.
Kwon-Chung, K. J. & Varma, A. (2006) Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Research 6, 574–587.
Ellis, D. H. & Pfeiffer, T. (1990) Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. The Lancet 336, 923–925.
Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., MacDougall, L., Boekhout, T., Kwon-Chung, K. J. & Meyer, W. (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences of the United States of America 101, 17258–17263.
Duncan, C., Schwantje, H., Stephen, C., Campbell, J. & Bartlett, K. (2006) Cryptococcus gattii in Wildlife of Vancouver Island, British Columbia, Canada. Journal of Wildlife Diseases 42, 175–178.
Grinsell, M., Weinhold, L. C., Cutler, J. E., Han, Y. M. & Kozel, T. R. (2001) In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages. Journal of Infectious Diseases 184, 479–487.
Goldman, D. L., Lee, S. C. & Casadevall, A. (1995) Tissue localization of Cryptococcus-neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infection and Immunity 63, 3448–3453.
Chuck, S. L. & Sande, M. A. (1989) Infections with Cryptococcus-neoformans in the acquired immunodeficiency syndrome. New England Journal of Medicine 321, 794–799.
Lu, H., Zhou, Y., Yin, Y., Pan, X. & Weng, X. (2005) Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. Journal of Clinical Microbiology 43, 2989–2990.
Ellerbroek, P. M., Walenkamp, A.M., Hoepelman, A.I. & Coenjaerts, F.E. (2004) Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Current Medical Chemistry 11, 253–266.
Monari, C., Retini, C., Casadevall, A., Netski, D., Bistoni, F., Kozel, T. R. & Vecchiarelli, A. (2003) Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. European Journal of Immunology 33, 1041–1051.
Yauch, L. E., Lam, J. S. & Levitz, S. M. (2006) Direct inhibition of T-cell responses by the cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathogens 2, e120.
Dong, Z. M. & Murphy, J. W. (1997) Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infection and Immunity 65, 557–563.
Shoham, S., Huang, C., Chen, J. M., Golenbock, D. T. & Levitz, S. M. (2001) Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. Journal of Immunology 166, 4620–4626.
Monari, C., Pericolini, E., Bistoni, G., Casadevall, A., Kozel, T. R. & Vecchiarelli, A. (2005) Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. Journal of Immunology 174, 3461–3468.
Vecchiarelli, A., Pietrella, D., Lupo, P., Bistoni, F., McFadden, D. C. & Casadevall, A. (2003) The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. Journal of Leukocyte Biology 74, 370–378.
Hill, J. O. & Harmsen, A. G. (1991) Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T-cells. Journal of Experimental Medicine 173, 755–758.
Huffnagle, G. B., Lipscomb, M. F., Lovchik, J. A., Hoag, K. A. & Street, N. E. (1994) The role of CD4(+) and CD8(+) T-cells in the protective inflammatory response to a pulmonary cryptococcal infection. Journal of Leukocyte Biology 55, 35–42.
Huffnagle, G. B., Yates, J. L. & Lipscomb, M. F. (1991) Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T-cells. Journal of Experimental Medicine 173, 793–800.
Huffnagle, G. B., Yates, J. L. & Lipscomb, M. F. (1991) T-cell-mediated immunity in the lung - a Cryptococcus neoformans pulmonary infection model using Scid and athymic nude-mice. Infection and Immunity 59, 1423–1433.
Mody, C. H., Lipscomb, M. F., Street, N. E. & Toews, G. B. (1990) Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. Journal of Immunology 144, 1472–1477.
Bennett, J. E. (1981) Cryptococcal skin test antigen: preparation variables and characterization. Infection and Immunity 32, 373–380.
Murphy, J. W. & Cozad, G. C. (1972) Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by hemolytic plaque technique. Infection and Immunity 5, 896.
Murphy, J. W. (1998) Protective cell-mediated immunity against Cryptococcus neoformans. Research in Immunology 149, 373–386.
Murphy, J. W. & Moorhead, J. W. (1982) Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. Journal of Immunology 128, 276–283.
Murphy, J. W. (1988) Influence of cryptococcal antigens on cell-mediated-immunity. Reviews of Infectious Diseases 10, S432–S435.
Levitz, S. M., Nong, S. H., Mansour, M. K., Huang, C. & Specht, C. A. (2001) Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proceedings of the National Academy of Sciences of the United States of America 98, 10422–10427.
Hoy, J. F., Murphy, J. W. & Miller, G. G. (1989) T-cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. Journal of Infectious Diseases 159, 116–119.
Chaka, W., Verheul, A. F., Vaishnav, V. V., Cherniak, R., Scharringa, J., Verhoef, J., Snippe, H. & Hoepelman, A. I. (1997) Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. Journal of Immunology 159, 2979–2985.
Pietrella, D., Cherniak, R., Strappini, C., Perito, S., Mosci, P., Bistoni, F. & Vecchiarelli, A. (2001) Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infection and Immunity 69, 2808–2814.
Chaka, W., Verheul, A. F., Vaishnav, V. V., Cherniak, R., Scharringa, J., Verhoef, J., Snippe, H. & Hoepelman, I. M. (1997) Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infection and Immunity 65, 272–278.
Pitzurra, L., Cherniak, R., Giammarioli, M., Perito, S., Bistoni, F. & Vecchiarelli, A. (2000) Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infection and Immunity 68, 558–563.
Hoag, K. A., Lipscomb, M. F., Izzo, A. A. & Street, N. E. (1997) IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. American Journal of Respiratory Cell and Molecular Biology 17, 733–739.
Kawakami, K., Qifeng, X., Tohyama, M., Qureshi, M. H. & Saito, A. (1996) Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clinical and Experimental Immunology 106, 468–474.
Kawakami, K., Tohyama, M., Teruya, K., Kudeken, N., Xie, Q. F. & Saito, A. (1996) Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunology and Medical Microbiology 13, 123–130.
Kawakami, K., Tohyama, M., Xie, Q. & Saito, A. (1996) IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clinical and Experimental Immunology 104, 208–214.
Mansour, M. K., Yauch, L. E., Rottman, J. B. & Levitz, S. M. (2004) Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infection and Immunity 72, 1746–1754.
Coenjaerts, F. E. J., Walenkamp, A. M. E., Mwinzi, P. N., Scharringa, J., Dekker, H. A. T., van Strijp, J. A. G., Cherniak, R. & Hoepelman, A. I. M. (2001) Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. Journal of Immunology 167, 3988–3995.
Kozel, T. R., Levitz, S. M., Dromer, F., Gates, M. A., Thorkildson, P. & Janbon, G. (2003) Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infection and Immunity 71, 2868–2875.
Ellerbroek, P. M., Lefeber, D. J., van Veghel, R., Scharringa, J., Brouwer, E., Gerwig, G. J., Janbon, G., Hoepelman, A. I. M. & Coenjaerts, F. E. J. (2004) O-Acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. Journal of Immunology 173, 7513–7520.
Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L. & Dromer, F. (2001) Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Molecular Microbiology 42, 453–467.
Mansour, M. K., E. Latz, and S. M. Levitz (2006) Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. Journal of Immunology 176, 3053–3061.
Buchanan, K. L. & Murphy, J. W. (1993) Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infection and Immunity 61, 2854–2865.
Dong, Z. M. & Murphy, J. W. (1993) Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infection and Immunity 61, 5067–5077.
Huang, C., Nong, S. H., Mansour, M. K., Specht, C. A. & Levitz, S. M. (2002) Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses. Infection and Immunity 70, 5485–5493.
Dubois, M., K. Gilles, J. K. Hamilton, P. A. Rebers, F. Smith (1951) A colorimetric method for the determination of sugars. Nature 168, 167.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wozniak, K.L., Levitz, S.M. (2009). Isolation and Purification of Antigenic Components of Cryptococcus . In: Rupp, S., Sohn, K. (eds) Host-Pathogen Interactions. Methods in Molecular Biology, vol 470. Humana Press. https://doi.org/10.1007/978-1-59745-204-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-204-5_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-886-7
Online ISBN: 978-1-59745-204-5
eBook Packages: Springer Protocols